Your browser doesn't support javascript.
loading
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11).
Yang, Yunpeng; Wang, Zhehai; Fang, Jian; Yu, Qitao; Han, Baohui; Cang, Shundong; Chen, Gongyan; Mei, Xiaodong; Yang, Zhixiong; Ma, Rui; Bi, Minghong; Ren, Xiubao; Zhou, Jianying; Li, Baolan; Song, Yong; Feng, Jifeng; Li, Juan; He, Zhiyong; Zhou, Rui; Li, Weimin; Lu, You; Wang, Yingyi; Wang, Lijun; Yang, Nong; Zhang, Yan; Yu, Zhuang; Zhao, Yanqiu; Xie, Conghua; Cheng, Ying; Zhou, Hui; Wang, Shuyan; Zhu, Donglei; Zhang, Wen; Zhang, Li.
Afiliação
  • Yang Y; Medical Oncology Department, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People's Republic of China.
  • Wang Z; Medical Oncology Department, Shandong Cancer Hospital, Jinan, Shandong, People's Republic of China.
  • Fang J; Department of Thoracic Oncology II, Peking University Cancer Hospital, Beijing, People's Republic of China.
  • Yu Q; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning City, Guangxi, People's Republic of China.
  • Han B; Department of Respiration, Shanghai Chest Hospital, Shanghai, People's Republic of China.
  • Cang S; Department of Oncology, The Henan Province Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Chen G; Department of Respiration, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.
  • Mei X; Department of Respiration, Anhui Provincial Hospital, Hefei, Anhui, People's Republic of China.
  • Yang Z; Department of Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
  • Ma R; Medical Oncology Department of Thoracic Cancer, Liaoning Cancer Hospital, Shenyang, Liaoning, People's Republic of China.
  • Bi M; Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
  • Ren X; Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Zhou J; Department of Respiratory Diseases, The First Affiliated Hospital College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Li B; Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Song Y; Department of Respiratory and Critical Care Medicine, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, Jiangsu, People's Republic of China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Li J; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, People's Republic of China.
  • He Z; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
  • Zhou R; Department of Respiration, Xiangya Second Hospital, Changsha, Hunan, People's Republic of China.
  • Li W; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • Lu Y; Department of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • Wang Y; Department of Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang L; Department of Tumor Radiotherapy, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, Hebei, People's Republic of China.
  • Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, People's Republic of China.
  • Zhang Y; Department of Oncology IV, First Hospital of Shijiazhuang, Shijiazhuang, Hebei, People's Republic of China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
  • Zhao Y; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
  • Cheng Y; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, Jilin, People's Republic of China.
  • Zhou H; Medical Science and Strategy Oncology, Innovent Biologics, Inc., Shanghai, People's Republic of China.
  • Wang S; Medical Science and Strategy Oncology, Innovent Biologics, Inc., Shanghai, People's Republic of China.
  • Zhu D; Medical Science and Strategy Oncology, Innovent Biologics, Inc., Shanghai, People's Republic of China.
  • Zhang W; Department of Biostatistics and Information, Innovent Biologics, Inc., Shanghai, People's Republic of China.
  • Zhang L; Medical Oncology Department, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People's Republic of China. Electronic address: zhangli@sysucc.org.cn.
J Thorac Oncol ; 15(10): 1636-1646, 2020 10.
Article em En | MEDLINE | ID: mdl-32781263
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Platina / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Platina / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article